CRADAs provide an exciting opportunity for PHS investigators to join with their colleagues from industry and academia in the joint pursuit of common research goals. Government scientists can leverage their own research resources, as well as serve the larger mission of PHS, to facilitate the development and commercialization of health-care pharmaceuticals and products. Companies also can leverage their own R&D efforts while collaborating in state-of-the-art PHS research.
The purpose of a CRADA is to make Government facilities, intellectual property, and expertise available for collaborative interactions to further the development of scientific and technological knowledge into useful, marketable products. Because issues involving patent rights lie at the heart of technology transfer, written CRADAs or MTAs should be considered for any outside collaborations and/or exchange of materials between PHS, industry, and academia.
Each PHS agency has a Technology Development Coordinator (TDC) who should be consulted at an early stage of collaboration by the company and the PHS investigator to assist in identifying and developing the proper documents and obtaining the required approvals.
|
|||||||||||||||||||||
|
|||||||||||||||||||||
